Analyst Ratings for Regeneron Pharma (REGN)
REGN Rating Summary
REGN Price Target Summary
- Highest: $1,189.00 (RBC Capital)
- Lowest: $720.00 (BofA Securities)
- Average: $1,029.05
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$1,029.05 (+13.5%)
* Over Last 12-Mos
Rating Score: 6.7 / 10 Percentile Rank: 72%
Rating Score: 6.7 / 10 Percentile Rank: 72%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/12/2024 | Bernstein SocGen Group | William Pickering | New Coverage | Outperform (N/A) |
1,125.00 (N/A) |
968.83 (906.54) |
-6.43% | Details |
3/1/2024 | Raymond James | Sean McCutcheon | New Coverage | Market Perform (N/A) |
N/A (N/A) |
966.09 (906.54) |
-6.16% | Details |